LEP Biomedical Ltd secured the Best Use of Technology Award at the Pharma Industry Awards 2025, honoured last year for an innovative approach to drug formulation that harnesses the precision and versatility of 3D printing to unlock breakthroughs previously beyond the reach of conventional manufacturing methods.

The core of LEP Biomedical's achievement lies in its application of 3D drug printing to ocular medicine. By engineering bespoke geometries tailored to individual anatomical profiles, the company has created drug delivery solutions that fit precisely where they need to, removing a fundamental constraint that has long limited therapeutic options in ophthalmology.

The technology's capabilities extend further still. Controllable mechanical properties and the ability to manage drug release across multiple parameters simultaneously give LEP Biomedical an extraordinarily fine degree of influence over how, where, and when a therapeutic agent takes effect.

Judges were clear on the significance of the submission. "LEP Biomedical's innovative approach to drug formulation using 3D printing has allowed breakthroughs through the creation of bespoke geometries that match the unique anatomy of the eye, controllable mechanical properties, and controlled drug release across multiple parameters," the panel stated.

The win reflects the standard the Pharma Industry Awards apply to technology-focused entries — where the most compelling submissions move beyond novelty to demonstrate that a technology is producing measurable, real-world pharmaceutical outcomes that advance the frontier of patient care.

As the 2026 awards cycle approaches, the challenge for Ireland's life sciences community is clear: who will bring the next technology application capable of reshaping how drugs are designed, delivered, and experienced by patients?

Visit the official awards website to explore past winners, read more about their achievements, and subscribe to the newsletter for updates and insights.